These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2889025)

  • 1. Susceptibility to coeliac disease involves genes in HLA-DP region.
    Niven MJ; Caffrey C; Sachs JA; Cassell PG; Gallagher RB; Kumar P; Hitman GA
    Lancet; 1987 Oct; 2(8562):805. PubMed ID: 2889025
    [No Abstract]   [Full Text] [Related]  

  • 2. The HLA-D region-associated MS-susceptibility genes may be located telomeric to the HLA-DP subregion.
    Olerup O; Hillert J; Fredrikson S
    Tissue Antigens; 1990 Jul; 36(1):37-9. PubMed ID: 1978948
    [No Abstract]   [Full Text] [Related]  

  • 3. A locus telomeric to HLA-DPB encodes susceptibility to coeliac disease.
    Rosenberg WM; Wordsworth BP; Jewell DP; Bell JI
    Immunogenetics; 1989; 30(4):307-10. PubMed ID: 2571589
    [No Abstract]   [Full Text] [Related]  

  • 4. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of HLA-D gene products in the normal and coeliac small bowel.
    Kelly J; Weir DG; Feighery C
    Tissue Antigens; 1988 Mar; 31(3):151-60. PubMed ID: 3376099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DP and coeliac disease: family and population studies.
    Caffrey C; Hitman GA; Niven MJ; Cassell PG; Kumar P; Fry L; Mackintosh P; Gallagher R; Feighery C; Weir D
    Gut; 1990 Jun; 31(6):663-7. PubMed ID: 1974234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation?
    Laadhar L; Toumi A; Kallel-Sellami M; Zitouni M; Bouraoui S; Maherzi A; Makni S; Ben Hariz M
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1286-90. PubMed ID: 19474744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical polymorphism of the HLA-DP heavy chain.
    Lotteau V; Teyton L; Tongio MM; Soulier A; Thomsen M; Sasportes M; Charron D
    Immunogenetics; 1987; 25(6):403-7. PubMed ID: 3596675
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
    Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction fragment length polymorphism of DP genes defines three new DP alleles.
    Mitsuishi Y; Urlacher A; Tongio MM; Mayer S
    Immunogenetics; 1987; 26(6):383-8. PubMed ID: 2889670
    [No Abstract]   [Full Text] [Related]  

  • 11. Restriction fragment polymorphism (RFLP) of a "new" HLA-DP specificity, CDP-HEI.
    Hyldig-Nielsen JJ; Odum N; Morling N; Svejgaard A
    Tissue Antigens; 1988 Mar; 31(3):161-3. PubMed ID: 2453937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synergistic three allele model for the HLA-linked components of coeliac disease predisposition.
    Louis EJ; Payami H; Klitz W; Lo SK; Thomson G
    Genet Epidemiol Suppl; 1986; 1():277-82. PubMed ID: 3569858
    [No Abstract]   [Full Text] [Related]  

  • 13. An extended HLA-D region haplotype associated with celiac disease.
    Howell MD; Smith JR; Austin RK; Kelleher D; Nepom GT; Volk B; Kagnoff MF
    Proc Natl Acad Sci U S A; 1988 Jan; 85(1):222-6. PubMed ID: 2893373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
    Eiermann TH; Martin A; Wölpl A; Goldmann SF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells.
    Holm K; Savilahti E; Koskimies S; Lipsanen V; Mäki M
    Gut; 1994 Jan; 35(1):55-60. PubMed ID: 8307450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes.
    Hyldig-Nielsen JJ; Morling N; Odum N; Ryder LP; Platz P; Jakobsen B; Svejgaard A
    Proc Natl Acad Sci U S A; 1987 Mar; 84(6):1644-8. PubMed ID: 2882511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HLA-DP polymorphism with DP alpha and DP beta probes and monoclonal antibodies: correlation with primed lymphocyte typing.
    Bodmer J; Bodmer W; Heyes J; So A; Tonks S; Trowsdale J; Young J
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4596-600. PubMed ID: 2885841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of HLA-DP specificities HLA-DPw1, -DPw2 and -DPw4: DP beta chain heterogeneity correlates with PLT subtyping.
    Baas EJ; Bontrop RE; Otting N; Giphart MJ
    Tissue Antigens; 1988 Jan; 31(1):5-13. PubMed ID: 2829386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmid clones in the HLA-DZ and -DP subregions.
    Blanck G; Strominger JL
    Hum Immunol; 1990 Mar; 27(3):265-8. PubMed ID: 2341304
    [No Abstract]   [Full Text] [Related]  

  • 20. Aetiopathogenesis of coeliac disease.
    Peña AS; Mearin ML
    Acta Gastroenterol Belg; 1986; 49(4):428-34. PubMed ID: 3107303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.